116 related articles for article (PubMed ID: 8328413)
1. EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma.
Bonomi PD; Finkelstein D; Aisner S; Ettinger D
Am J Clin Oncol; 1993 Aug; 16(4):342-5. PubMed ID: 8328413
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.
Loehrer PJ; Kim K; Aisner SC; Livingston R; Einhorn LH; Johnson D; Blum R
J Clin Oncol; 1994 Jun; 12(6):1164-8. PubMed ID: 8201378
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Giaccone G; Ardizzoni A; Kirkpatrick A; Clerico M; Sahmoud T; van Zandwijk N
J Clin Oncol; 1996 Mar; 14(3):814-20. PubMed ID: 8622029
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for advanced thymoma. Preliminary results of an intergroup study.
Loehrer PJ; Perez CA; Roth LM; Greco A; Livingston RB; Einhorn LH
Ann Intern Med; 1990 Oct; 113(7):520-4. PubMed ID: 2203292
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for invasive thymoma. A 13-year experience.
Fornasiero A; Daniele O; Ghiotto C; Piazza M; Fiore-Donati L; Calabró F; Rea F; Fiorentino MV
Cancer; 1991 Jul; 68(1):30-3. PubMed ID: 2049749
[TBL] [Abstract][Full Text] [Related]
6. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
Loehrer PJ; Jiroutek M; Aisner S; Aisner J; Green M; Thomas CR; Livingston R; Johnson DH
Cancer; 2001 Jun; 91(11):2010-5. PubMed ID: 11391579
[TBL] [Abstract][Full Text] [Related]
7. Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.
Zucali PA; De Pas T; Palmieri G; Favaretto A; Chella A; Tiseo M; Caruso M; Simonelli M; Perrino M; De Vincenzo F; Toffalorio F; Damiano V; Pasello G; Garbella E; Ali M; Conforti F; Ottaviano M; Cioffi A; De Placido S; Giordano L; Bertossi M; Destro A; Di Tommaso L; Santoro A
J Clin Oncol; 2018 Feb; 36(4):342-349. PubMed ID: 29240542
[TBL] [Abstract][Full Text] [Related]
8. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of invasive thymoma.
Fornasiero A; Daniele O; Ghiotto C; Sartori F; Rea F; Piazza M; Fiore-Donati L; Morandi P; Aversa SM; Paccagnella A
J Clin Oncol; 1990 Aug; 8(8):1419-23. PubMed ID: 2380761
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potential of Docetaxel plus Cisplatin Chemotherapy for Myasthenia Gravis Patients with Metastatic Thymoma.
Qi G; Liu P; Dong H; Gu S; Yang H; Xue Y
Tohoku J Exp Med; 2017 Apr; 241(4):281-286. PubMed ID: 28381664
[TBL] [Abstract][Full Text] [Related]
11. A Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma.
Gbolahan OB; Porter RF; Salter JT; Yiannoutsos C; Burns M; Chiorean EG; Loehrer PJ
J Thorac Oncol; 2018 Dec; 13(12):1940-1948. PubMed ID: 30121390
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of invasive thymoma. A retrospective study of 22 cases.
Göldel N; Böning L; Fredrik A; Hölzel D; Hartenstein R; Wilmanns W
Cancer; 1989 Apr; 63(8):1493-500. PubMed ID: 2466548
[TBL] [Abstract][Full Text] [Related]
13. Long-lasting response to cis-platinum in recurrent malignant thymoma: case report.
Cocconi G; Boni C; Cuomo A
Cancer; 1982 May; 49(10):1985-7. PubMed ID: 7200392
[TBL] [Abstract][Full Text] [Related]
14. Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide.
Lara PN; Bonomi PD; Faber LP
Chest; 1996 Oct; 110(4):1115-7. PubMed ID: 8874280
[TBL] [Abstract][Full Text] [Related]
15. Resection and perfusion thermochemotherapy: a new approach for the treatment of thymic malignancies with pleural spread.
Refaely Y; Simansky DA; Paley M; Gottfried M; Yellin A
Ann Thorac Surg; 2001 Aug; 72(2):366-70. PubMed ID: 11515868
[TBL] [Abstract][Full Text] [Related]
16. Refractory recurrent thymoma successfully treated with long-acting somatostatin analogue and prednisolone.
Ito J; Sekiya M; Miura K; Yoshimi K; Suzuki T; Seyama K; Izumi H; Uekusa T; Takahashi K
Intern Med; 2009; 48(12):1061-4. PubMed ID: 19525599
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of invasive or metastatic thymoma: report of 11 cases.
Fornasiero A; Daniele O; Sperandio P; Morandi P; Fosser VP; Cartei G; Fiorentino MV
Cancer Treat Rep; 1984 Oct; 68(10):1205-10. PubMed ID: 6543151
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-containing chemotherapy in the treatment of invasive thymoma: report of five cases.
Giaccone G; Musella R; Bertetto O; Donadio M; Calciati A
Cancer Treat Rep; 1985 Jun; 69(6):695-7. PubMed ID: 4040423
[TBL] [Abstract][Full Text] [Related]
19. Salvage chemotherapy for recurrent invasive thymoma.
Musi M; Di Vito F; Rosti G
Chest; 1997 Aug; 112(2):572-3. PubMed ID: 9266913
[No Abstract] [Full Text] [Related]
20. High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience.
Hanna N; Gharpure VS; Abonour R; Cornetta K; Loehrer PJ
Bone Marrow Transplant; 2001 Sep; 28(5):435-8. PubMed ID: 11593315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
